图书馆订阅: Guest
Begell Digital Portal Begell 数字图书馆 电子图书 期刊 参考文献及会议录 研究收集
真核基因表达评论综述™
影响因子: 1.841 5年影响因子: 1.927 SJR: 0.649 SNIP: 0.516 CiteScore™: 1.96

ISSN 打印: 1045-4403
ISSN 在线: 2162-6502

真核基因表达评论综述™

DOI: 10.1615/CritRevEukaryotGeneExpr.2015013057
pages 145-152

Adipose-Derived Stromal Vascular Fraction Cells: Update on Clinical Utility and Efficacy

Seongho Han
Department of Family Medicine, College of Medicine, Dong-A University, Busan, Republic of Korea
Hyun Min Sun
Department of Medicine, College of Medicine, Catholic Kwandong University, Gangneung, Republic of Korea
Ki-Chul Hwang
Department of Medicine, College of Medicine, Catholic Kwandong University, Gangneung, Republic of Korea
Sung-Whan Kim
Department of Medicine, College of Medicine, Catholic Kwandong University, Gangneung, Republic of Korea

ABSTRACT

Adipose tissue has emerged as an attractive cell source in tissue engineering and regenerative medicine because it can be easily collected and enriched with stem/progenitor cell populations. The stromal vascular fraction (SVF) derived from adipose tissue contains heterogeneous cell populations such as mesenchymal progenitor/stem cells, preadipocytes, endothelial cells, pericytes, T cells, and M2 macrophages. SVF-derived mesenchymal progenitor/stem cells can be easily expanded in vitro and have the potential to create diverse lineages of cells. Although there have been issues related to their isolation and purification, SVF cells demonstrate regenerative potential in damaged tissues or organs through paracrine and differentiation mechanisms. Furthermore, SVF cells augment immunological tolerance by promoting inhibitory macrophages and T regulatory cells and by decreasing ongoing inflammation. Numerous implantations of freshly isolated, autologous adipose tissue-derived SVF cells in cosmetic surgeries and in a wide variety of other specialties support the safety of SVF cells and have accelerated their clinical application. Despite these attractive advantages of SVF cells in clinical interventions, to our knowledge the recent status of clinical studies of various diseases has not been fully investigated. Therefore this article describes recent advances in the clinical use of SVF cells, as well as the associated challenges and future directions for this field of research. We also speculate that verification of the efficacy and safety of SVF cells requires more basic experimental research, using a standard isolation protocol, and larger randomized clinical trials of the utility of SVF cells in various diseases.


Articles with similar content:

Dendritic Cell Tumor Killing Activity and Its Potential Applications in Cancer Immunotherapy
Critical Reviews™ in Immunology, Vol.33, 2013, issue 1
Neale Hanke, Darya Alizadeh, Nicolas Larmonier, Emmanuel Katsanis
Interleukin 35−Producing B Cells (i35-Breg): A New Mediator of Regulatory B-Cell Functions in CNS Autoimmune Diseases
Critical Reviews™ in Immunology, Vol.35, 2015, issue 1
Charles E. Egwuagu, Cheng-Rong Yu
Stem Cells: A New Paradigm in Medical Therapeutics
Journal of Long-Term Effects of Medical Implants, Vol.20, 2010, issue 3
Sadanand D. Mankikar
Minimally Invasive Approaches to Inguinal Hernia Repair
Journal of Long-Term Effects of Medical Implants, Vol.20, 2010, issue 2
Dennis Leung, Michael B. Ujiki
Bone Tissue Engineering: Recent Advances and Challenges
Critical Reviews™ in Biomedical Engineering, Vol.40, 2012, issue 5
Syam P. Nukavarapu, Cato T. Laurencin, Ami R. Amini